<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>20409767</identifier>
<setSpec>1695-9531</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Oyarzabal Irigoyen, M</dc:author>
<dc:author>González Casado, I</dc:author>
<dc:author>Rodríguez Rigual, M</dc:author>
<dc:author>Torres Lacruz, M</dc:author>
<dc:author>Gómez Gila, A</dc:author>
<dc:author>Hermoso López, F</dc:author>
<dc:author>Rica Etxebarria, I</dc:author>
<dc:author>García Cuartero, B</dc:author>
<dc:author>Luzuriaga Tomás, C</dc:author>
<dc:author>Barrio Castellanos, R</dc:author>
<dc:description xml:lang="en">This article reports on the Spanish Position Statement for the Diabetes Pediátric Group for the Spanish Pediatric Endocrinology Society (SEEP) on continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes. The practical issues about their indications, appropriate candidates, feasibility, and limits are outlined. The conclusions are based on the comprehensive review and balanced assessment of the evidence base on the international consensus and consensual answers to these questions for the participants.</dc:description>
<dc:type>Consensus Development Conference</dc:type>
<dc:language>es</dc:language>
<dc:date>2010 May </dc:date>
<dc:title xml:lang="es">Documento de consenso sobre tratamiento con infusión subcutánea continua de insulina de la diabetes tipo 1 en la edad pediátrica.</dc:title>
<dc:title xml:lang="en">[Consensus document on continuous subcutaneous insulin infusion (CSII) treatment in paediatrics with type I diabetes].</dc:title>
<dc:publisher>Anales de pediatria (Barcelona, Spain : 2003)</dc:publisher>
</metadata>
</record>
</pubmed-document>
